Clinical Trial: Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: ACTHAR Gel for Chronic Pulmonary Sarcoidosis (ACPS)

Brief Summary: An randomized trial of two maintenance doses of Acthar Gel for patients with chronic pulmonary sarcoidosis. Patients will be observed for 24 weeks of treatment.